CroíValve raises €3.2 million angel investment -

CroíValve raise €3.2 million

Posted in News by Faun on 24 Apr 2019.

CroíValve is an early stage medical device company who are focused on developing a minimally invasive device for the treatment of tricuspid regurgitation.

The severe cardiac disease affects more than 550,000 people every year in the EU and US. Less than 1% of these usually elderly patients receive surgical treatment, as they are deemed too frail.

Picture shows: CroíValve CEO Dr Lucy O' O'Keeffe (centre) receiving funding.

The Dublin med-tech start-up joined The Liffey Trust Enterprise Centre in January 2019. Since then they have gone on to raise a record breaking €3.2 million in Angel Investment for its minimally invasive heart treatment device.

The funding will support the continued development of CroíValve’s innovative technology

‘CroíValve was established from a desire to bring a new, safe treatment option that can change and save lives’- CroíValve CEO Dr Lucy O' O'Keeffe

To learn more visit or read full Silicon-republic Article here